NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global movement is preparing to shift the narrative from the ubiquitous pink ribbons of early detection to the stark, often-overlooked realities of Stage 4 disease. On October 13, 2026, designated as National Metastatic Breast Cancer (MBC) Awareness Day, more than 325 landmarks across the globe will be bathed in teal, green, and pink. This coordinated display, known as the #LightUpMBC campaign, aims to honor those lost to the disease, support those currently living with it, and—most crucially—drive funding toward the research required to find a cure.
While October is traditionally dominated by messages regarding mammograms and the "celebration of survivorship," the #LightUpMBC initiative, spearheaded by the non-profit METAvivor Research and Support, serves as a poignant reminder that for many, breast cancer is not a battle that ends with a final treatment. It is a lifelong, terminal condition that claims the lives of approximately 117 people in the United States every single day.
Main Facts: A Global Spectrum of Awareness
The #LightUpMBC campaign is a massive logistical and advocacy undertaking involving 195 cities across all 50 U.S. states and 20 countries. The choice of colors—teal, green, and pink—is intentional and symbolic. Teal represents healing and spirituality; green represents the triumph of spring over winter and the renewal of life; and pink signifies the breast cancer origin. Together, they form the official ribbon of metastatic breast cancer.
The Landmark Participation
The scale of the 2026 illumination is unprecedented. Iconic structures scheduled to participate include:
- North America: One World Trade Center (New York City), Willis Tower (Chicago), Philadelphia City Hall, and the binational Niagara Falls.
- International: Ness Bridge (Inverness, Scotland) and Mactan-Cebu Airport (Philippines).
- Historical Significance: The Memorial Bridge in Portsmouth, New Hampshire, which in 2017 became the first landmark ever to light up for MBC, will once again lead the charge.
The Virtual Centerpiece
Complementing the physical light displays is #LightUpMBC Live, a virtual broadcast streaming at 8 p.m. ET / 5 p.m. PT. This free event is designed to bridge the gap between patient advocacy and scientific advancement. Hosted by Tami Eagle Bowling, an 11-year MBC survivor and campaign director, and Broadway’s Kara Lindsay, the program features a blend of personal testimonials, musical performances from Tony Award winners, and insights from leading oncological researchers.
Chronology: From a Single Bridge to a Global Beacon
The journey of #LightUpMBC is a testament to the power of grassroots advocacy born from personal loss. The campaign was founded by Laura Inahara in memory of her best friend, Jessica Moore.
In 2017, Jessica Moore was a young woman living with Stage 4 breast cancer. Her simple wish was to see a local landmark illuminated in the MBC awareness colors to bring attention to the specific needs of metastatic patients. At the age of 36, Jessica passed away, but her vision did not die with her.
Inahara took up the mantle, starting with the Memorial Bridge in New Hampshire. What began as a local tribute quickly resonated with a community that felt largely excluded from the mainstream "pink" narrative. By 2019, the movement had gained enough momentum to partner with METAvivor, a non-profit dedicated exclusively to funding Stage 4 research.
Over the last nine years, the campaign has evolved from a single bridge to a multi-national phenomenon. To date, #LightUpMBC has raised more than $2.7 million for critical research. The 2026 iteration marks the largest expansion in the campaign’s history, reflecting a growing global recognition that "awareness" without "funding" is insufficient for those facing a terminal diagnosis.
Supporting Data: The Biological and Statistical Reality of MBC
To understand the urgency behind the #LightUpMBC campaign, one must look at the sobering statistics and the biological nature of the disease.
What is Metastatic Breast Cancer?
Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the bloodstream or lymphatic system to form new tumors in distant organs. The most common sites of metastasis are the bones, liver, lungs, and brain. Despite its location in other organs, it remains breast cancer and is treated with breast cancer protocols.
There is currently no cure for MBC. While some patients are "de novo" (diagnosed at Stage 4 from the start), many others are diagnosed years or even decades after completing treatment for early-stage (Stage 1-3) cancer.
The 2026 Forecast
According to data from the National Cancer Institute’s SEER program, an estimated 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to roughly 117 deaths per day, or one death every 12 minutes.
The Research Gap
Historically, only a small fraction of overall breast cancer research funding (estimated by some advocacy groups at less than 7-10%) has been directed toward the metastatic stage—the stage that actually kills patients. METAvivor was founded to correct this imbalance, ensuring that 100% of net proceeds from campaigns like #LightUpMBC go directly to Stage 4 research grants.
Official Responses: Voices from the Frontlines
The leaders of this movement emphasize that while the lights are beautiful, the objective is clinical progress.
Dr. Kelly Shanahan, METAvivor Board President, provides a unique perspective as both a physician and a patient. Diagnosed with MBC in 2013, she has defied the average life expectancy for the disease.
“When I was diagnosed, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan stated. “My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important because it focuses specifically on how to stop the spread and how to treat resistance. #LightUpMBC is the biggest contributor to this research and serves as a vital way to unify our community.”
Laura Inahara, Founder of #LightUpMBC, reflects on the legacy of the campaign’s inspiration.
“Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love,” Inahara said. “We are teaching patients how to advocate for themselves and providing the financial engine for the research that will eventually save lives.”
Tami Eagle Bowling, Campaign Director and #LightUpMBC Live Host, highlights the emotional resonance of the event.
“Living with MBC for 11 years has taught me that we need more than just hope; we need science. Our live stream brings together the best of both—the stories of those in the trenches and the scientists working in the labs.”
Implications: Shifting the Paradigm from Terminal to Chronic
The #LightUpMBC campaign carries significant implications for the future of oncology and patient advocacy. By demanding a seat at the table during Breast Cancer Awareness Month, MBC advocates are forcing a shift in how the public perceives the disease.
1. Redefining "Success" in Treatment
For the metastatic community, success is not defined by "finishing treatment" but by "stability." The goal of METAvivor-funded research is to transform MBC from a terminal illness into a manageable chronic condition, similar to HIV or Type 1 diabetes. This requires a constant pipeline of new therapies, as the cancer often evolves and becomes resistant to current drugs.
2. The Power of "Actionable" Awareness
The #LightUpMBC campaign serves as a model for "Actionable Awareness." It moves beyond passive observation by providing a direct link between a visual event (the lighting of a landmark) and a financial outcome (funding research). In an era of "slacktivism," this campaign requires physical participation from landmark owners and financial commitment from donors.
3. Community and Visibility
Perhaps the most profound implication is the psychological impact on patients. For many living with Stage 4 disease, the "pink" celebrations of October can feel isolating or even exclusionary. #LightUpMBC provides a dedicated space where the specific grief, resilience, and needs of the metastatic community are centered.
4. Scientific Advancement
The $2.7 million raised thus far has funded numerous grants that undergo a rigorous peer-review process involving both scientists and patient advocates. By funding projects that specifically target metastasis, the campaign is accelerating the development of precision medicine and targeted therapies that may one day render the "terminal" label obsolete.
As the sun sets on October 13, 2026, the glow of teal, green, and pink across hundreds of cities will stand as a silent but powerful vigil. It is a reminder that while the shadows of MBC are long, the collective light of research, advocacy, and community remains undimmed.
How to Participate:
The public is encouraged to take photos of participating landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor.
Viewing Information:
- What: #LightUpMBC Live
- When: Tuesday, October 13, 2026, at 8 p.m. ET / 5 p.m. PT
- Where: Streaming on METAvivor’s YouTube, Facebook Live, and LiveOne.
- More Info: www.lightupmbc.org
About the Author
